(MOPETT) Trial

09.02.2015 • Views

Share Embed Flag

(MOPETT) Trial

(MOPETT) Trial

DOWNLOAD ePAPER

cardio.se

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

• 66% had BNP or Trop I elevation<br />

• RV enlargement 12/61(20%) and 14/60<br />

(23%)<br />

• RV hypokinesia 3/61(4.9%) and 4/60(6.6%)

1
2
3
4
5
6
7
8
17
18
19
20
21
22
23
24
25
28
29
30
31
32
33
34
35
37
38

Management of patients with palpitations: a position paper from the ...

Hela numret kan lÃ¤sas hÃ¤r. - Svenska CardiologfÃ¶reningen

LÃ¤s hela numret. - Svenska CardiologfÃ¶reningen

EssÃ¤frÃ¥ga 2

Kateterablation vid ventrikulÃ¤ra arrytmier

HF ACTION slides

the TRILOGY ACS trial

HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)

KortsvarsfrÃ¥gor

High-Dose Clopidogrel

CHAMPION PHOENIX Presentation Slides.pptx

Svensk Cardiologi 3 2010 - Svenska CardiologfÃ¶reningen

DANPACE Trial ESC presentation final

Svensk Cardiologi 4 2012 - Svenska CardiologfÃ¶reningen

• 66% had BNP or Trop I elevation • RV enlargement 12/61(20%) and 14/60 (23%) • RV hypokinesia 3/61(4.9%) and 4/60(6.6%)

TG CG p Value Initial PASPmm Hg 50±6 51±7 0.40 Change within 48 hours - 16±3 -5±2

Page 1 and 2: Moderate Pulmonary Embolism Treated
Page 3 and 4: Pulmonary Embolism • >100,000 ann
Page 5 and 6: • Standard dose t-PA 100mg in 2 h
Page 7 and 8: “ SAFER DOSE t-PA”
Page 17 and 18: MOPETT Trial 121 Patients TT= 61 CG
Page 19 and 20: Secondary Endpoints • In-Hospital
Page 21 and 22: Evaluation of Troponin I and BNP Ec
Page 23 and 24: “Safe Dose” t-PA • For ≥ 50
Page 25: Concomitant Anticoagulation TG •
Page 29: Anticoagulation CG • Enoxaparin (
Page 33 and 34: Secondary Endpoints TG N= 61 CG N=6
Page 35: Changes in PASP ( mmHg )
Page 38: HAPPY NOWRUZ